Abstract

Background:Familial exudative vitreoretinopathy (FEVR) is a hereditary disorder characterized by impaired vascularization of parts of the peripheral retina. Autosomal dominant FEVR (adFEVR), a major form of FEVR and assigned to chromosome 11q13–23 (EVR1) locus, is caused by deletion mutations in the C-terminal region of the frizzled-4 (FZD4) gene. This paper describes the clinical phenotype of adFEVR in two Japanese families with two different mutations in the FZD4gene. Methods:We encountered three Japanese patients with adFEVR and studied them using mutation analysis of the FZD4gene with PCR, sequencing, and a restriction enzyme digestion. Results:Two previously unreported missense mutations, p.H69Y and p.C181R, were identified in the N-terminal extracellular region of two of the patients. This region was highly conserved among other vertebrate species and FZD family members, unlike the C-terminal region. Co-segregation analysis revealed that all affected individuals carried one of these mutations, while unaffected individuals did not. The mutations were not detected in normal individuals (n = 120). The affected individuals had mild to severe retinal abnormalities. Conclusions: FZD4mutations in either the N- or C-terminal region underlie adFEVR, which indicates that FZD4plays an important role in retinal angiogenesis. Analysis of FZD4mutations in families with adFEVR is useful for genetic counseling and for early diagnosis.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.